A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/19 (2006.01) A61K 38/13 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01) A61K 39/395 (2006.01) C07K 14/74 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2056450
2056450 9014835 PCTABS00002 Subjects may be immunized against rheumatoid arthritis by administering the peptide Q(K/R)RAA in immunogenic form in a protocol leading to preferential expansion of suppressor and/or cytotoxic T-cells rather than helper T-cells. This preferential expansion can be effected by administration of interleukin-6 and/or cyclosporin A. Alternatively, the Q(K/R)RAA peptide coupled to the invariant region of a Class I histocompatibility sequence may be administered. Also disclosed are pharmaceutical compositions useful in the vaccination protocols.
Carson Dennis A.
Roudier Jean
Ade & Company
Carson Dennis A.
Roudier Jean
Scripps Clinic And Research Foundation
LandOfFree
Method to treat rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to treat rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to treat rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1641166